Difference between revisions of "MALE5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
(Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo...")
 
 
(One intermediate revision by the same user not shown)
Line 17: Line 17:
 
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
 +
|CHAPTER 2 (TUMOURS OF THE KIDNEY)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Clear_cell_renal_cell_carcinoma|Clear cell renal cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 27: Line 48:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Multilocular_cystic_renal_neoplasm_of_low_malignant_potential|Multilocular cystic renal neoplasm of low malignant potential]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 36: Line 59:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Renal_papillary_adenoma|Renal papillary adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 45: Line 70:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Papillary_renal_cell_carcinoma|Papillary renal cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 54: Line 81:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Oncocytoma_of_the_kidney|Oncocytoma of the kidney]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 63: Line 92:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Chromophobe_renal_cell_carcinoma|Chromophobe renal cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 72: Line 103:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Other_oncocytic_tumours_of_the_kidney|Other oncocytic tumours of the kidney]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 81: Line 114:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Collecting_duct_carcinoma|Collecting duct carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 90: Line 125:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Clear_cell_papillary_renal_cell_tumour|Clear cell papillary renal cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 99: Line 136:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Mucinous_tubular_and_spindle_cell_carcinoma|Mucinous tubular and spindle cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 108: Line 147:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Tubulocystic_renal_cell_carcinoma|Tubulocystic renal cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 117: Line 158:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Acquired_cystic_disease-associated_renal_cell_carcinoma|Acquired cystic disease-associated renal cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 126: Line 169:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Eosinophilic_solid_and_cystic_renal_cell_carcinoma|Eosinophilic solid and cystic renal cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 135: Line 180:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Renal_cell_carcinoma_NOS|Renal cell carcinoma NOS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 144: Line 191:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:TFE3-rearranged_renal_cell_carcinomas|TFE3-rearranged renal cell carcinomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 153: Line 202:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:TFEB-altered_renal_cell_carcinomas|TFEB-altered renal cell carcinomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 162: Line 213:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:ELOC_(formerly_TCEB1)-mutated_renal_cell_carcinoma|ELOC (formerly TCEB1)-mutated renal cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 171: Line 224:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Fumarate_hydratase-deficient_renal_cell_carcinoma|Fumarate hydratase-deficient renal cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 180: Line 235:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Succinate_dehydrogenase-deficient_renal_cell_carcinoma|Succinate dehydrogenase-deficient renal cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 189: Line 246:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:ALK-rearranged_renal_cell_carcinomas|ALK-rearranged renal cell carcinomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 198: Line 257:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:SMARCB1-deficient_renal_medullary_carcinoma|SMARCB1-deficient renal medullary carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 207: Line 268:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Metanephric_adenoma|Metanephric adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 216: Line 279:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Metanephric_adenofibroma|Metanephric adenofibroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 225: Line 290:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Metanephric_stromal_tumour|Metanephric stromal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 234: Line 301:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Mixed_epithelial_and_stromal_tumour_of_the_kidney|Mixed epithelial and stromal tumour of the kidney]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 243: Line 312:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Paediatric_cystic_nephroma|Paediatric cystic nephroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 252: Line 323:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Classic_angiomyolipoma_/_PEComa_of_the_kidney|Classic angiomyolipoma / PEComa of the kidney]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 261: Line 334:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Epithelioid_angiomyolipoma_/_epithelioid_PEComa_of_the_kidney|Epithelioid angiomyolipoma / epithelioid PEComa of the kidney]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 270: Line 345:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Renal_haemangioblastoma|Renal haemangioblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 279: Line 356:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Juxtaglomerular_cell_tumour|Juxtaglomerular cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 288: Line 367:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Renomedullary_interstitial_cell_tumour|Renomedullary interstitial cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 297: Line 378:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Ossifying_renal_tumour_of_infancy|Ossifying renal tumour of infancy]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 306: Line 389:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Congenital_mesoblastic_nephroma|Congenital mesoblastic nephroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 315: Line 400:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Rhabdoid_tumour_of_the_kidney|Rhabdoid tumour of the kidney]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 324: Line 411:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Clear_cell_sarcoma_of_the_kidney|Clear cell sarcoma of the kidney]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 333: Line 422:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Nephrogenic_rests_|Nephrogenic rests]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 342: Line 433:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Cystic_partially_differentiated_nephroblastoma|Cystic partially differentiated nephroblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 351: Line 444:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Nephroblastoma|Nephroblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 360: Line 455:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Germ_cell_tumours_of_the_kidney|Germ cell tumours of the kidney]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 369: Line 466:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 3 (TUMOURS OF THE URINARY TRACT)
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Urothelial_papilloma|Urothelial papilloma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 387: Line 497:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Inverted_urothelial_papilloma|Inverted urothelial papilloma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 396: Line 508:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Papillary_urothelial_neoplasm_of_low_malignant_potential|Papillary urothelial neoplasm of low malignant potential]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 405: Line 519:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Non-invasive_papillary_urothelial_carcinoma,_low-grade|Non-invasive papillary urothelial carcinoma, low-grade]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 414: Line 530:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Non-invasive_papillary_urothelial_carcinoma,_high-grade|Non-invasive papillary urothelial carcinoma, high-grade]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 423: Line 541:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Urothelial_carcinoma_in_situ|Urothelial carcinoma in situ]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 432: Line 552:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Invasive_urothelial_carcinoma|Invasive urothelial carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 441: Line 563:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Squamous_papilloma_of_the_urothelial_tract|Squamous papilloma of the urothelial tract]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 450: Line 574:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Verrucous_carcinoma_of_the_bladder|Verrucous carcinoma of the bladder]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 459: Line 585:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Pure_squamous_carcinoma_of_the_urothelial_tract|Pure squamous carcinoma of the urothelial tract]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 468: Line 596:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Villous_adenoma|Villous adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 477: Line 607:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Adenocarcinoma_NOS|Adenocarcinoma NOS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 486: Line 618:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Urachal_carcinoma|Urachal carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 495: Line 629:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Diverticular_carcinoma|Diverticular carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 504: Line 640:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Littre_gland_adenocarcinoma_of_the_urethra|Littre gland adenocarcinoma of the urethra]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 513: Line 651:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Skene_gland_adenocarcinoma_of_the_urethra|Skene gland adenocarcinoma of the urethra]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 522: Line 662:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Cowper_gland_adenocarcinoma_of_the_urethra|Cowper gland adenocarcinoma of the urethra]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 531: Line 673:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Clear_cell_adenocarcinoma_of_the_urinary_tract|Clear cell adenocarcinoma of the urinary tract]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 540: Line 684:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Endometrioid_carcinoma_of_the_urinary_tract|Endometrioid carcinoma of the urinary tract]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 549: Line 695:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 4 (TUMOURS OF THE PROSTATE)
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_cystadenoma|Prostatic cystadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 567: Line 726:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:High-grade_prostatic_intraepithelial_neoplasia|High-grade prostatic intraepithelial neoplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 576: Line 737:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Intraductal_carcinoma_of_the_prostate|Intraductal carcinoma of the prostate]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 585: Line 748:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_acinar_adenocarcinoma|Prostatic acinar adenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 594: Line 759:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_ductal_adenocarcinoma|Prostatic ductal adenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 603: Line 770:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Treatment-related_neuroendocrine_prostatic_carcinoma|Treatment-related neuroendocrine prostatic carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 612: Line 781:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Adenosquamous_carcinoma_of_the_prostate| Adenosquamous carcinoma of the prostate]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 621: Line 792:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Squamous_cell_carcinoma_of_the_prostate| Squamous cell carcinoma of the prostate]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 630: Line 803:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Adenoid_cystic_(basal_cell)_carcinoma_of_the_prostate| Adenoid cystic (basal cell) carcinoma of the prostate]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 639: Line 814:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_stromal_tumour_of_uncertain_malignant_potential|Prostatic stromal tumour of uncertain malignant potential]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 648: Line 825:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_stromal_sarcoma|Prostatic stromal sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 657: Line 836:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 5 (TUMOURS OF THE SIMINAL VESICLE)
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Cystadenoma_of_the_seminal_vesicle|Cystadenoma of the seminal vesicle]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 675: Line 867:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Adenocarcinoma_of_the_seminal_vesicle|Adenocarcinoma of the seminal vesicle]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 684: Line 878:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Squamous_cell_carcinoma_of_the_seminal_vesicle|Squamous cell carcinoma of the seminal vesicle]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 693: Line 889:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Mixed_epithelial_and_stromal_tumour_of_the_seminal_vesicle|Mixed epithelial and stromal tumour of the seminal vesicle]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 702: Line 900:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 2 (TUMOURS OF THE TESTIS)
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Germ_cell_neoplasia_in_situ| Germ cell neoplasia in situ]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 720: Line 931:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Specific_forms_of_intratubular_germ_cell_neoplasia| Specific forms of intratubular germ cell neoplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 729: Line 942:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Gonadoblastoma| Gonadoblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 738: Line 953:
 
|
 
|
 
|-
 
|-
 +
|[[MALE5:_Seminoma| Seminoma]]
 +
|Disease
 +
|
 +
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Embryonal_carcinoma| Embryonal carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Yolk_sac_tumour,_postpubertal-type| Yolk sac tumour, postpubertal-type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Choriocarcinoma| Choriocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Placental_site_trophoblastic_tumour| Placental site trophoblastic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Epithelioid_trophoblastic_tumour| Epithelioid trophoblastic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Cystic_trophoblastic_tumour| Cystic trophoblastic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Teratoma,_postpubertal-type|Teratoma, postpubertal-type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Teratoma_with_somatic-type_malignancy|Teratoma with somatic-type malignancy]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Mixed_germ_cell_tumours| Mixed germ cell tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Regressed_germ_cell_tumours| Regressed germ cell tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Spermatocytic_tumour|Spermatocytic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Teratoma,_prepubertal-type| Teratoma, prepubertal-type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Yolk_sac_tumour,_prepubertal-type|Yolk sac tumour, prepubertal-type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Testicular_neuroendocrine_tumour,_prepubertal-type|Testicular neuroendocrine tumour, prepubertal-type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Mixed_teratoma_and_yolk_sac_tumour,_prepubertal-type|Mixed teratoma and yolk sac tumour, prepubertal-type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Leydig_cell_tumour| Leydig cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Sertoli_cell_tumour| Sertoli cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Large_cell_calcifying_Sertoli_cell_tumour|Large cell calcifying Sertoli cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Adult_granulosa_cell_tumour| Adult granulosa cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Juvenile_granulosa_cell_tumour| Juvenile granulosa cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Tumours_in_the_fibroma_thecoma_group| Tumours in the fibroma thecoma group]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Mixed_sex_cord_stromal_tumour|Mixed sex cord stromal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Signet_ring_stromal_tumour|Signet ring stromal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Myoid_gonadal_stromal_tumour|Myoid gonadal stromal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Sex_cord_stromal_tumour_NOS|Sex cord stromal tumour NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 7 (TUMOURS OF THE TESTICULAR ADNEXA)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:_Serous_cystadenoma| Serous cystadenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Serous_tumour_of_borderline_malignancy| Serous tumour of borderline malignancy]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Serous_cystadenocarcinoma| Serous cystadenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Mucinous_cystadenoma| Mucinous cystadenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Mucinous_borderline_tumour| Mucinous borderline tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Mucinous_cystadenocarcinoma| Mucinous cystadenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Endometrioid_tumours| Endometrioid tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Clear_cell_adenocarcinoma| Clear cell adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Brenner_tumour| Brenner tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Adenoma_of_the_collecting_ducts_and_rete_testis|Adenoma of the collecting ducts and rete testis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Adenocarcinoma_of_the_collecting_ducts_and_rete_testis|Adenocarcinoma of the collecting ducts and rete testis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Adenomatoid_tumour| Adenomatoid tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Well-differentiated_papillary_mesothelial_tumour| Well-differentiated papillary mesothelial tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Mesothelioma| Mesothelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Cystadenoma_of_the_epididymis| Cystadenoma of the epididymis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Papillary_cystadenoma_of_the_epididymis| Papillary cystadenoma of the epididymis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Adenocarcinoma_of_the_epididymis| Adenocarcinoma of the epididymis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Squamous_cell_carcinoma_of_the_epididymis|Squamous cell carcinoma of the epididymis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Melanotic_neuroectodermal_tumour_of_the_epididymis| Melanotic neuroectodermal tumour of the epididymis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 8 (TUMOURS OF THE PENIS AND SCROTUM)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:Condyloma_acuminatum|Condyloma acuminatum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Penile_intraepithelial_neoplasia,_HPV-associated|Penile intraepithelial neoplasia, HPV-associated]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Differentiated_penile_intraepithelial_neoplasia,_HPV-independent|Differentiated penile intraepithelial neoplasia, HPV-independent]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:HPV-associated_squamous_cell_carcinoma|HPV-associated squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:HPV-independent_squamous_cell_carcinoma|HPV-independent squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Squamous_cell_carcinoma_NOS| Squamous cell carcinoma NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Penile_adenosquamous_and_mucoepidermoid_carcinomas| Penile adenosquamous and mucoepidermoid carcinomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Extramammary_Paget_disease|Extramammary Paget disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Basal_cell_carcinoma_of_the_scrotum|Basal cell carcinoma of the scrotum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 9 (NEUROENDOCRINE NEOPLASMS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:Well-differentiated_neuroendocrine_tumour|Well-differentiated neuroendocrine tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Small_cell_neuroendocrine_carcinoma|Small cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Large_cell_neuroendocrine_carcinoma|Large cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Mixed_neuroendocrine_neoplasms|Mixed neuroendocrine neoplasms]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Paraganglioma|Paraganglioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 10 (MESENCHYMAL TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:The_angiofibroma_family_of_tumours|The angiofibroma family of tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Haemangioma|Haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Angiosarcoma|Angiosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Glomus_tumour|Glomus tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Myointimoma|Myointimoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Myopericytoma|Myopericytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Extrarenal_PEComa|Extrarenal PEComa]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Leiomyoma|Leiomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Leiomyosarcoma|Leiomyosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Synovial_sarcoma|Synovial sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 11 (HAEMATOLYMPHOID TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:Extranodal_marginal_zone_lymphoma_of_MALT|Extranodal marginal zone lymphoma of MALT]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Plasmacytoma|Plasmacytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Juvenile_xanthogranuloma| Juvenile xanthogranuloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 12 (MELANOCYTIC LESIONS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:Mucosal_melanoma|Mucosal melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 13 (METASTASES IN THE GENITOURINARY SYSTEM)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:Metastasis_to_the_urinary_tract|Metastasis to the urinary tract]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metastasis_to_the_kidney|Metastasis to the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metastasis_to_the_testis_and_paratestis|Metastasis to the testis and paratestis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 14 (GENETIC TUMOUR SYNDROMES OF TEH URINARY AND MALE GENITAL TRACTS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Birt-Hogg-Dube_syndrome|Birt-Hogg-Dube syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Hereditary_papillary_renal_carcinoma|Hereditary papillary renal carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma_syndrome|Hereditary leiomyomatosis and renal cell carcinoma syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Succinate_dehydrogenase-deficient_tumour_syndromes|Succinate dehydrogenase-deficient tumour syndromes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Hereditary_phaeochromocytoma-paraganglioma_syndromes|Hereditary phaeochromocytoma-paraganglioma syndromes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Tuberous_sclerosis|Tuberous sclerosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Genitourinary_system_and_Lynch_syndrome|Genitourinary system and Lynch syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Hereditary_tumour_syndromes_associated_with_homologous_recombination_pathway_mutations|Hereditary tumour syndromes associated with homologous recombination pathway mutations]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Carney_complex|Carney complex]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
 
|Disease
 
|Disease
 
|
 
|

Latest revision as of 08:52, 27 February 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Urinary and Male Genital Tumours (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
CHAPTER 2 (TUMOURS OF THE KIDNEY)
Clear cell renal cell carcinoma Disease
Multilocular cystic renal neoplasm of low malignant potential Disease
Renal papillary adenoma Disease
Papillary renal cell carcinoma Disease
Oncocytoma of the kidney Disease
Chromophobe renal cell carcinoma Disease
Other oncocytic tumours of the kidney Disease
Collecting duct carcinoma Disease
Clear cell papillary renal cell tumour Disease
Mucinous tubular and spindle cell carcinoma Disease
Tubulocystic renal cell carcinoma Disease
Acquired cystic disease-associated renal cell carcinoma Disease
Eosinophilic solid and cystic renal cell carcinoma Disease
Renal cell carcinoma NOS Disease
TFE3-rearranged renal cell carcinomas Disease
TFEB-altered renal cell carcinomas Disease
ELOC (formerly TCEB1)-mutated renal cell carcinoma Disease
Fumarate hydratase-deficient renal cell carcinoma Disease
Succinate dehydrogenase-deficient renal cell carcinoma Disease
ALK-rearranged renal cell carcinomas Disease
SMARCB1-deficient renal medullary carcinoma Disease
Metanephric adenoma Disease
Metanephric adenofibroma Disease
Metanephric stromal tumour Disease
Mixed epithelial and stromal tumour of the kidney Disease
Paediatric cystic nephroma Disease
Classic angiomyolipoma / PEComa of the kidney Disease
Epithelioid angiomyolipoma / epithelioid PEComa of the kidney Disease
Renal haemangioblastoma Disease
Juxtaglomerular cell tumour Disease
Renomedullary interstitial cell tumour Disease
Ossifying renal tumour of infancy Disease
Congenital mesoblastic nephroma Disease
Rhabdoid tumour of the kidney Disease
Clear cell sarcoma of the kidney Disease
Nephrogenic rests Disease
Cystic partially differentiated nephroblastoma Disease
Nephroblastoma Disease
Germ cell tumours of the kidney Disease
CHAPTER 3 (TUMOURS OF THE URINARY TRACT)
Urothelial papilloma Disease
Inverted urothelial papilloma Disease
Papillary urothelial neoplasm of low malignant potential Disease
Non-invasive papillary urothelial carcinoma, low-grade Disease
Non-invasive papillary urothelial carcinoma, high-grade Disease
Urothelial carcinoma in situ Disease
Invasive urothelial carcinoma Disease
Squamous papilloma of the urothelial tract Disease
Verrucous carcinoma of the bladder Disease
Pure squamous carcinoma of the urothelial tract Disease
Villous adenoma Disease
Adenocarcinoma NOS Disease
Urachal carcinoma Disease
Diverticular carcinoma Disease
Littre gland adenocarcinoma of the urethra Disease
Skene gland adenocarcinoma of the urethra Disease
Cowper gland adenocarcinoma of the urethra Disease
Clear cell adenocarcinoma of the urinary tract Disease
Endometrioid carcinoma of the urinary tract Disease
CHAPTER 4 (TUMOURS OF THE PROSTATE)
Prostatic cystadenoma Disease
High-grade prostatic intraepithelial neoplasia Disease
Intraductal carcinoma of the prostate Disease
Prostatic acinar adenocarcinoma Disease
Prostatic ductal adenocarcinoma Disease
Treatment-related neuroendocrine prostatic carcinoma Disease
Adenosquamous carcinoma of the prostate Disease
Squamous cell carcinoma of the prostate Disease
Adenoid cystic (basal cell) carcinoma of the prostate Disease
Prostatic stromal tumour of uncertain malignant potential Disease
Prostatic stromal sarcoma Disease
CHAPTER 5 (TUMOURS OF THE SIMINAL VESICLE)
Cystadenoma of the seminal vesicle Disease
Adenocarcinoma of the seminal vesicle Disease
Squamous cell carcinoma of the seminal vesicle Disease
Mixed epithelial and stromal tumour of the seminal vesicle Disease
CHAPTER 2 (TUMOURS OF THE TESTIS)
Germ cell neoplasia in situ Disease
Specific forms of intratubular germ cell neoplasia Disease
Gonadoblastoma Disease
Seminoma Disease
Embryonal carcinoma Disease
Yolk sac tumour, postpubertal-type Disease
Choriocarcinoma Disease
Placental site trophoblastic tumour Disease
Epithelioid trophoblastic tumour Disease
Cystic trophoblastic tumour Disease
Teratoma, postpubertal-type Disease
Teratoma with somatic-type malignancy Disease
Mixed germ cell tumours Disease
Regressed germ cell tumours Disease
Spermatocytic tumour Disease
Teratoma, prepubertal-type Disease
Yolk sac tumour, prepubertal-type Disease
Testicular neuroendocrine tumour, prepubertal-type Disease
Mixed teratoma and yolk sac tumour, prepubertal-type Disease
Leydig cell tumour Disease
Sertoli cell tumour Disease
Large cell calcifying Sertoli cell tumour Disease
Adult granulosa cell tumour Disease
Juvenile granulosa cell tumour Disease
Tumours in the fibroma thecoma group Disease
Mixed sex cord stromal tumour Disease
Signet ring stromal tumour Disease
Myoid gonadal stromal tumour Disease
Sex cord stromal tumour NOS Disease
CHAPTER 7 (TUMOURS OF THE TESTICULAR ADNEXA)
Serous cystadenoma Disease
Serous tumour of borderline malignancy Disease
Serous cystadenocarcinoma Disease
Mucinous cystadenoma Disease
Mucinous borderline tumour Disease
Mucinous cystadenocarcinoma Disease
Endometrioid tumours Disease
Clear cell adenocarcinoma Disease
Brenner tumour Disease
Adenoma of the collecting ducts and rete testis Disease
Adenocarcinoma of the collecting ducts and rete testis Disease
Adenomatoid tumour Disease
Well-differentiated papillary mesothelial tumour Disease
Mesothelioma Disease
Cystadenoma of the epididymis Disease
Papillary cystadenoma of the epididymis Disease
Adenocarcinoma of the epididymis Disease
Squamous cell carcinoma of the epididymis Disease
Melanotic neuroectodermal tumour of the epididymis Disease
CHAPTER 8 (TUMOURS OF THE PENIS AND SCROTUM)
Condyloma acuminatum Disease
Penile intraepithelial neoplasia, HPV-associated Disease
Differentiated penile intraepithelial neoplasia, HPV-independent Disease
HPV-associated squamous cell carcinoma Disease
HPV-independent squamous cell carcinoma Disease
Squamous cell carcinoma NOS Disease
Penile adenosquamous and mucoepidermoid carcinomas Disease
Extramammary Paget disease Disease
Basal cell carcinoma of the scrotum Disease
CHAPTER 9 (NEUROENDOCRINE NEOPLASMS)
Well-differentiated neuroendocrine tumour Disease
Small cell neuroendocrine carcinoma Disease
Large cell neuroendocrine carcinoma Disease
Mixed neuroendocrine neoplasms Disease
Paraganglioma Disease
CHAPTER 10 (MESENCHYMAL TUMOURS)
The angiofibroma family of tumours Disease
Solitary fibrous tumour Disease
Inflammatory myofibroblastic tumour Disease
Haemangioma Disease
Angiosarcoma Disease
Glomus tumour Disease
Myointimoma Disease
Myopericytoma Disease
Extrarenal PEComa Disease
Leiomyoma Disease
Leiomyosarcoma Disease
Rhabdomyosarcoma Disease
Synovial sarcoma Disease
Extrarenal rhabdoid tumour Disease
Desmoplastic small round cell tumour Disease
CHAPTER 11 (HAEMATOLYMPHOID TUMOURS)
Extranodal marginal zone lymphoma of MALT Disease
Diffuse large B-cell lymphoma Disease
Plasmacytoma Disease
Juvenile xanthogranuloma Disease
CHAPTER 12 (MELANOCYTIC LESIONS)
Mucosal melanoma Disease
CHAPTER 13 (METASTASES IN THE GENITOURINARY SYSTEM)
Metastasis to the urinary tract Disease
Metastasis to the kidney Disease
Metastasis to the testis and paratestis Disease
CHAPTER 14 (GENETIC TUMOUR SYNDROMES OF TEH URINARY AND MALE GENITAL TRACTS)
Von Hippel-Lindau syndrome Disease
Birt-Hogg-Dube syndrome Disease
Hereditary papillary renal carcinoma Disease
Hereditary leiomyomatosis and renal cell carcinoma syndrome Disease
Succinate dehydrogenase-deficient tumour syndromes Disease
BAP1 tumour predisposition syndrome Disease
Hereditary phaeochromocytoma-paraganglioma syndromes Disease
Tuberous sclerosis Disease
Genitourinary system and Lynch syndrome Disease
Hereditary tumour syndromes associated with homologous recombination pathway mutations Disease
Carney complex Disease
Peutz-Jeghers syndrome Disease
Retrieved from "https://content.ccga.io/index.php?title=MALE5:Volunteer_Assignments_and_Opportunities&oldid=14261"